Allegro Diagnostics
Originally published Oct. 10.
Veracyte to Buy Allegro Dx for $21M
NEW YORK (GenomeWeb) – Veracyte announced after the close of the market Thursday that it will acquire Allegro Diagnostics for $7.8 million in cash and $13.2 million in common stock.
MDx/CDx Focus: New Studies on Veracyte's Afirma, Allegro's BronchoGen; MyRA App Globally Launched
Premium
Veracyte Reports that Adding BRAF Mutation Testing Doesn't Improve Upon its Afirma Test
The headline for this story has been updated from a previous version to clarify that the company has completed enrollment for the trial.
HTG Molecular Diagnostics has named Steve Hagan to be vice president of molecular diagnostic sales. Hagan previously was at Ventana Medical Systems, where he was senior director of digital pathology and workflow commercialization.
Jun 29, 2012
Jul 19, 2011
Apr 27, 2010
People in the News: Apr 27, 2010
Premium
Apr 20, 2010
Paired Ends: Apr 20, 2010
Premium
Jan 5, 2010
Oct 22, 2009